Compare Stocks: LFST, FMS, TEM, and DVA

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DVA DaVita	$180.34 +1.4%	$213.07	$101.00 ▼ $247.49	$11.34B	0.88	1.04 million shs	528,789 shs
FMS Fresenius Medical Care AG & Co. KGaA	$23.45 -0.3%	$23.96	$20.02 ▼ $27.64	$12.63B	0.77	799,889 shs	877,369 shs
LFST LifeStance Health Group	$12.15 -1.1%	$10.99	$4.77 ▼ $12.97	$4.76B	1.14	4.30 million shs	4.29 million shs
TEM Tempus AI	$68.48 -0.4%	$53.97	$40.77 ▼ $104.32	$12.40B	3.58	7.34 million shs	5.21 million shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DVA DaVita	+0.74%	-0.14%	-24.47%	-8.89%	+29.50%
FMS Fresenius Medical Care AG & Co. KGaA	-0.05%	-0.39%	-4.40%	+8.89%	-7.19%
LFST LifeStance Health Group	+0.99%	-0.65%	+12.66%	+61.37%	+127.83%
TEM Tempus AI	+3.87%	+39.24%	+61.00%	+45.71%	-9.45%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DVA DaVita	$180.34 +1.4%	$213.07	$101.00 ▼ $247.49	$11.34B	0.88	1.04 million shs	528,789 shs
FMS Fresenius Medical Care AG & Co. KGaA	$23.45 -0.3%	$23.96	$20.02 ▼ $27.64	$12.63B	0.77	799,889 shs	877,369 shs
LFST LifeStance Health Group	$12.15 -1.1%	$10.99	$4.77 ▼ $12.97	$4.76B	1.14	4.30 million shs	4.29 million shs
TEM Tempus AI	$68.48 -0.4%	$53.97	$40.77 ▼ $104.32	$12.40B	3.58	7.34 million shs	5.21 million shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DVA DaVita	+0.74%	-0.14%	-24.47%	-8.89%	+29.50%
FMS Fresenius Medical Care AG & Co. KGaA	-0.05%	-0.39%	-4.40%	+8.89%	-7.19%
LFST LifeStance Health Group	+0.99%	-0.65%	+12.66%	+61.37%	+127.83%
TEM Tempus AI	+3.87%	+39.24%	+61.00%	+45.71%	-9.45%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DVA DaVita	2.38	Hold	$221.75	22.96% Upside
FMS Fresenius Medical Care AG & Co. KGaA	1.55	Reduce	$23.57	0.50% Upside
LFST LifeStance Health Group	2.73	Moderate Buy	$12.38	1.85% Upside
TEM Tempus AI	2.41	Hold	$65.69	-4.07% Downside

Current Analyst Ratings Breakdown

Latest LFST, FMS, TEM, and DVA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/20/2026	TEM Tempus AI	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$70.00 ➝ $80.00
8/19/2026	LFST LifeStance Health Group	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$16.00 ➝ $18.00
8/14/2026	LFST LifeStance Health Group	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$9.00 ➝ $13.00
8/12/2026	TEM Tempus AI	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/11/2026	LFST LifeStance Health Group	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
8/7/2026	DVA DaVita	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Buy	$201.00 ➝ $220.00
8/7/2026	DVA DaVita	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$220.00
8/7/2026	DVA DaVita	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$220.00
8/7/2026	DVA DaVita	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Hold	$250.00 ➝ $215.00
8/7/2026	LFST LifeStance Health Group	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$15.00 ➝ $16.00
8/6/2026	FMS Fresenius Medical Care AG & Co. KGaA	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Market Perform	$25.50 ➝ $25.80

(Data available from 8/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DVA DaVita	$13.64B	0.84	$22.18 per share	8.13	($7.55) per share	-23.89
FMS Fresenius Medical Care AG & Co. KGaA	$19.43B	0.65	$5.54 per share	4.23	$29.29 per share	0.80
LFST LifeStance Health Group	$1.42B	3.31	$0.17 per share	72.29	$3.81 per share	3.19
TEM Tempus AI	$1.27B	9.72	N/A	N/A	$2.47 per share	27.72

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DVA DaVita	$746.80M	$12.22	14.76	10.45	0.59	6.05%	-217.63%	5.07%	10/28/2026 (Estimated)
FMS Fresenius Medical Care AG & Co. KGaA	$1.11B	$1.93	12.15	9.98	4.37	4.83%	9.28%	4.16%	11/3/2026 (Estimated)
LFST LifeStance Health Group	$9.66M	$0.13	93.47	52.83	N/A	3.19%	3.39%	2.33%	11/5/2026 (Estimated)
TEM Tempus AI	-$245.03M	-$1.44	N/A	N/A	N/A	-17.77%	-50.28%	-10.33%	11/3/2026 (Estimated)

Latest LFST, FMS, TEM, and DVA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	LFST LifeStance Health Group	$0.0328	$0.06	+$0.0273	$0.06	$414.58 million	$435.35 million
8/4/2026	Q2 2026	DVA DaVita	$3.88	$4.02	+$0.14	$4.02	$3.50 billion	$3.55 billion
8/3/2026	Q2 2026	FMS Fresenius Medical Care AG & Co. KGaA	$0.6160	$0.66	+$0.0440	$0.46	$5.48 billion	$5.55 billion
7/30/2026	Q2 2026	TEM Tempus AI	-$0.1428	-$0.04	+$0.1028	$0.03	$379.69 million	$382.49 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DVA DaVita	N/A	N/A	N/A	N/A	N/A
FMS Fresenius Medical Care AG & Co. KGaA	$0.60	2.56%	+2.66%	31.09%	N/A
LFST LifeStance Health Group	N/A	N/A	N/A	N/A	N/A
TEM Tempus AI	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DVA DaVita	N/A	1.47	1.41
FMS Fresenius Medical Care AG & Co. KGaA	0.43	1.07	0.75
LFST LifeStance Health Group	0.18	1.38	1.38
TEM Tempus AI	3.06	3.30	3.16

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DVA DaVita	90.12%
FMS Fresenius Medical Care AG & Co. KGaA	8.37%
LFST LifeStance Health Group	85.50%
TEM Tempus AI	24.22%

Insider Ownership

Company	Insider Ownership
DVA DaVita	1.90%
FMS Fresenius Medical Care AG & Co. KGaA	N/A
LFST LifeStance Health Group	3.50%
TEM Tempus AI	24.26%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DVA DaVita	78,000	63.80 million	62.59 million	Optionable
FMS Fresenius Medical Care AG & Co. KGaA	1,488	537.13 million	N/A	Optionable
LFST LifeStance Health Group	10,961	387.83 million	374.26 million	Optionable
TEM Tempus AI	3,800	180.43 million	136.66 million	N/A

LFST, FMS, TEM, and DVA Headlines

Recent News About These Companies

Top Performing Leveraged/Inverse ETFs: 08/23/2026

4 hours ago | etftrends.comE

Promising Artificial Intelligence Stocks To Keep An Eye On - August 26th

August 26 at 12:02 PM | marketbeat.com

Tempus AI (NASDAQ:TEM) CEO Ryan Fukushima Sells 14,286 Shares of Stock

August 26 at 5:37 AM | insidertrades.com

Tempus AI receives FDA clearance for pulmonary hypertension tool

August 25 at 7:58 PM | mobihealthnews.comM

Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 14,286 Shares

August 25 at 5:06 PM | marketbeat.com

What's Going On With Tempus AI Stock on Monday?

August 24 at 2:02 PM | benzinga.com

Tempus AI (TEM) Stock Surges as FDA Approves AI-Powered Heart Disease Detection Tool

August 24 at 1:46 PM | blockonomi.com

Tempus AI (NASDAQ:TEM) Stock Price Down 7.4% - Should You Sell?

August 24 at 12:59 PM | marketbeat.com

Promising Artificial Intelligence Stocks To Follow Now - August 24th

August 24 at 12:00 PM | marketbeat.com

Best-Performing Leveraged ETF Areas of Last Week

August 24 at 9:01 AM | zacks.com

Artificial Intelligence Stocks To Watch Today - August 23rd

August 23 at 12:00 PM | marketbeat.com

Tempus AI's Breakneck Rally Faces Its First Test: Can Fundamentals Keep Pace?

August 23 at 8:46 AM | ad-hoc-news.deA

Why Tempus AI Skyrocketed This Week

August 23 at 7:15 AM | fool.com

Promising Artificial Intelligence Stocks To Keep An Eye On - August 20th

August 23 at 3:02 AM | americanbankingnews.com

Tempus AI, Inc. (NASDAQ:TEM) Given Average Recommendation of "Hold" by Analysts

August 23 at 2:29 AM | americanbankingnews.com

Tempus AI, Inc. (NASDAQ:TEM) Given Consensus Recommendation of "Hold" by Brokerages

August 23 at 2:28 AM | marketbeat.com

Tempus AI (NASDAQ:TEM) Trading 8.3% Higher Following Analyst Upgrade

August 23 at 1:41 AM | americanbankingnews.com

Artificial Intelligence Stocks To Follow Now - August 22nd

August 22, 2026 | marketbeat.com

Tempus AI: Winning With Precision Medicine

August 22, 2026 | seekingalpha.com

Has Tempus AI (TEM) Run Too Far Ahead Of Its Valuation Narrative?

August 22, 2026 | uk.finance.yahoo.com

What to Know About the CFO of Tempus AI's Latest Insider Transaction Filing

August 22, 2026 | fool.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

LFST, FMS, TEM, and DVA Company Descriptions

DaVita NYSE:DVA

$180.34 +2.54 (+1.43%)

As of 03:58 PM Eastern

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

$23.45 -0.06 (-0.26%)

As of 03:58 PM Eastern

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

LifeStance Health Group NASDAQ:LFST

$12.15 -0.13 (-1.06%)

As of 04:00 PM Eastern

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Tempus AI NASDAQ:TEM

$68.48 -0.25 (-0.36%)

As of 04:00 PM Eastern

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest LFST, FMS, TEM, and DVA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest LFST, FMS, TEM, and DVA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

LFST, FMS, TEM, and DVA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

LFST, FMS, TEM, and DVA Company Descriptions

DaVita NYSE:DVA

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

LifeStance Health Group NASDAQ:LFST

Tempus AI NASDAQ:TEM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest LFST, FMS, TEM, and DVA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest LFST, FMS, TEM, and DVA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

LFST, FMS, TEM, and DVA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

LFST, FMS, TEM, and DVA Company Descriptions

DaVita NYSE:DVA

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

LifeStance Health Group NASDAQ:LFST

Tempus AI NASDAQ:TEM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools